ENTRY       D11121                      Drug
NAME        Gimsilumab (USAN/INN)
FORMULA     C6726H10428N1764O2184S38
EXACT_MASS  152070.8542
MOL_WEIGHT  152163.7449
SEQUENCE    (Heavy chain)
            EVQLVESGGG LVQPGGSLRL SCAASGFTFS RHWMHWLRQV PGKGPVWVSR INGAGTSITY
            ADSVRGRFTI SRDNANNTLF LQMNSLRADD TALYFCARAN SVWFRGLFDY WGQGTPVTVS
            SASTKGPSVF PLAPSSKSTS GGTAALGCLV KDYFPEPVTV SWNSGALTSG VHTFPAVLQS
            SGLYSLSSVV TVPSSSLGTQ TYICNVNHKP SNTKVDKKVE PKSCDKTHTC PPCPAPELLG
            GPSVFLFPPK PKDTLMISRT PEVTCVVVDV SHEDPEVKFN WYVDGVEVHN AKTKPREEQY
            NSTYRVVSVL TVLHQDWLNG KEYKCKVSNK ALPAPIEKTI SKAKGQPREP QVYTLPPSRD
            ELTKNQVSLT CLVKGFYPSD IAVEWESNGQ PENNYKTTPP VLDSDGSFFL YSKLTVDKSR
            WQQGNVFSCS VVHEALHNHY TQKSLSLSPG K
            (Light chain)
            EIVLTQSPVT LSVSPGERVT LSCRASQSVS TNLAWYQQKL GQGPRLLIYG ASTRATDIPA
            RFSGSGSETE FTLTISSLQS EDFAVYYCQQ YDKWPDTFGQ GTKLEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H96, H148-H204, H224-L214, H230-H'230, H233-H'233, H265-H325, H371-H429, H'22-H'96, H'148-H'204, H'224-L'214, H'265-H'325, H'371-H'429, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
EFFICACY    Anti-inflammatory
  TYPE      Monoclonal antibody
COMMENT     Treatment of rheumatoid arthritis
TARGET      CSF2 [HSA:1437] [KO:K05427]
  PATHWAY   hsa04060(1437)  Cytokine-cytokine receptor interaction
            hsa04668(1437)  TNF signaling pathway
            hsa05323(1437)  Rheumatoid arthritis
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               CSF and other factors
                CSF2
                 D11121  Gimsilumab (USAN/INN)
DBLINKS     CAS: 1648796-29-5
            PubChem: 376219045
///
